Rethinking 'good' cholesterol; PSA test debate

This is the VOA Special English Health Report.

A study has raised questions about a widely held belief involving cholesterol. The belief is that high levels of so-called good cholesterol in the blood can reduce the risk of a heart attack.

The medical name for "good" cholesterol is high-density lipoprotein, or HDL. Doctors commonly believe it reduces the risk of heart attack by removing fatty deposits that can block the flow of blood in the arteries of the heart.

But Dr. Sekar Kathiresan at Massachusetts General Hospital in Boston says the effects of high HDL have never been proven. He says the new study that he and other researchers did suggests that HDL cholesterol does not affect the risk of heart attack.

SEKAR KATHIRESAN: "This has been the major assumption over the last 30 years, that if you raise HDL cholesterol, the risk for heart disease will be lowered. And I think we have now broken that assumption, broken that link using this gene variant."

The researchers say about four percent of people have a genetic change that gives them a naturally high level of HDL. The study found that those who were genetically "programmed" to have higher HDL levels were just as likely to suffer heart attacks as those who were not.

A second analysis looked at 14 gene variants that increase good cholesterol. Dr. Kathiresan says people with the most variants had no more protection against heart attacks than anyone else.

But he says there is no dispute about the effects of low-density lipoprotein, or LDL. LDL, the so-called bad cholesterol, causes a buildup of fatty substances inside arteries and increases the risk of heart attack.

Dr. Kathiresan and his colleagues published their findings in the Lancet medical journal.

Another widely held medical belief has also come into question recently. For years, men over the age of 40 have been told to get a simple blood test to see if they have prostate cancer. Now, experts on a government committee are advising them not to. Dr. Virginia Moyer heads the United States Preventive Services Task Force.

VIRGINIA MOYER: "Close to two-thirds of older men have prostate cancer and yet the huge majority of them never have a problem from it in their lifetime."

The task force examined two large studies before deciding that treating the cancer found by the PSA test can do more harm than good. Effects of the treatment can include a loss of sexual ability and bladder control, as well as other problems including heart attacks.

Some experts support the findings of the task force, but others disagree. Urologist Deepak Kapoor says in about 20 years of PSA testing, death rates for prostate cancer have dropped by 38 percent.

And that's the VOA Special English Health Report. I'm Steve Ember.

high-density lipoprotein: 高密度脂蛋白

Related stories:

純素食有風險 不妨“彈性素食”

Antibody could reverse diabetes

Study: cutting salt might increase heart risks

Cholesterol-lowering foods may prove healthier

（來源：VOA 編輯：旭燕）